A Study of HMPL-306 in Patients With IDH1 and/or IDH2 Mutation of Relapsed/Refractory Myeloid Leukemia/Neoplasms
Clinical trial NCT04272957 · UNKNOWN
Trial details
- NCT number
- NCT04272957
- Sponsor
- Hutchison Medipharma Limited
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-14
- Primary completion
- 2021-06-30
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.